Folic Acid (Folate) or vitamin B 9 is an essential vitamin that is required for nucleic acid synthesis, erythropoiesis, and as a cofactor for methanol toxicity. It is recommended in pregnant women for organogenesis and to reduce the incidence of neural tube defects (spina bifida).
Folic Acid (Folate) Uses:
-
Megaloblastic and macrocytic anemias due to folate deficiency:
- It is indicated for the treatment of megaloblastic anemia due to folate deficiency.
-
Off Label Use of Folic Acid in Adults:
- As an alternative to leucovorin calcium (calcium folinate), it may be used as an adjunctive cofactor therapy in methanol toxicity.
- It is indicated in pregnant women at high risk of giving birth to babies with neural tube defects
- It may be used as a supplement to reduce toxicity associated with antifolate chemotherapy.
Folic Acid (Folate) Dose in Adults
Folic Acid (Folate) Dose in the treatment of Megaloblastic and macrocytic anemias due to folate deficiency:
- 1 to 5 mg orally once a day.
- Doses up to 15 mg once a day may be given in severe cases.
-
Manufacturer's labeling:
- Oral, IM, IV, SubQ: Initial:
- 0.4 to 1 mg/day.
- Maintenance dose:
- 4 mg/day
- Oral, IM, IV, SubQ: Initial:
- Pregnant and lactating women:
- Maintenance dose of 0.8 mg/day
Folic Acid (Folate) Dose in the treatment of Methanol poisoning (off-label):
- 50 to 70 mg intravenous every four hours or
- 50 mg orally every 3 to 4 hours.
- Folic acid treatment should continue until the complete elimination of methanol and formic acid.
- It should never be used as monotherapy. Cofactors are adjunctive to antidotal therapy.
Folic Acid (Folate) Dose in the Prevention of neural tube defects (off-label):
-
Females of childbearing potential:
- 4 mg/day orally daily or
- 0.4 to 0.8 mg/day.
- Folate supplementation should be initiated at least one month prior to conception and continue until at least 12 weeks of gestation.
-
Females at high risk, those with a family history of neural tube defects, or those who have had a previous pregnancy with a neural tube defect:
- 4 mg/day orally.
- Folic acid supplementation should be initiated at least 3 months before conception and continued until at least the 12 weeks of gestation.
Folic Acid (Folate) Dose as Supplementation to reduce toxicity associated with antifolate chemotherapy (off-label):
-
To reduce toxicity associated with pemetrexed:
- Give folic acid 0.35 to 1 mg once a day. Initiate folic acid treatment 1 to 3 weeks before initiating pemetrexed treatment.
- Continue for three weeks after the last dose of pemetrexed.
- Administer folic acid with intramuscular cyanocobalamin supplementation.
-
To reduce toxicity associated with pralatrexate:
- Give folic acid 1 to 1.25 mg once a day.
- Beginning folate supplementation at least 10 days before initiating pralatrexate treatment.
- The treatment must be continued for 30 days after the last pralatrexate dose.
- It should be administered with intramuscular cyanocobalamin supplementation.
Folic Acid (Folate) Dose in Childrens
Adequate intake (AI) of Folic Acid (Folate):
-
1-6 months:
- 65 mcg/day
-
7-12 months:
- 80 mcg/day
Recommended daily allowance (RDA) of Folic Acid (Folate):
-
1-3 years:
- 150 mcg/day
-
4-8 years:
- 200 mcg/day
-
9-13 years:
- 300 mcg/day
-
Adolescents ≥14 years:
- 400 mcg/day
Folic Acid (Folate) Dose in the treatment of Anemia (folic acid deficiency):
Oral, IM, IV, SubQ:
-
Infants:
- 1 mg/day
-
Children <4 years:
- Up to 0.3 mg/day
-
Children >4 years and Adolescents:
- 4 mg/day
Folic Acid (Folate) Dose in the maintenance requirement of folic acid as Parenteral nutrition:
Intravenous administration:
-
Infants:
- 56 mcg/kg/day
-
Children and Adolescents younger than 13 years:
- 140 mcg/day
-
Adolescents older than 13 years:
- 400 mcg/day
Folic Acid (Folate) Dose in the prevention of Gingival hyperplasia due to phenytoin:
-
Children ≥6 years and Adolescents:
- 5 mg/day orally.
Folic Acid (Folate) use in Pregnancy (Pregnancy Risk Category: A)
- Folic Acid (Folate), a water-soluble vitamin, can cross the placental boundary. Pregnancy is when maternal needs increase.
- Folic acid is a preventive measure that reduces the risk of neural tube defects (spina bifida).
- Folate supplementation should be started before any female patient plans to get pregnant.
- Spina-bifida is a condition in which a woman's risk of having a baby with a neural tube defect (spina bifida), should be taken at higher doses.
- Folate supplementation is required for pregnant women with folate deficiency.
Folic acid use during breastfeeding:
- Folic Acid (Folate), which is found in human breastmilk, is an essential nutrient. Breastfeeding women have a higher daily intake.
- Except faor severe deficiencies, maternal concentrations are not affected.
Folic Acid (Folate) Dose in Kidney Disease:
Dose adjustment in not recommended in patients with kidney disease.
Folic Acid (Folate) Dose in Liver disease:
Dose adjustment is not recommended in patients with liver disease.
Side effects of Folic Acid (Folate):
-
Cardiovascular:
- Flushing (slight)
-
Central nervous system:
- Malaise (general)
-
Dermatologic:
- Erythema
- Pruritus
- Skin rash
-
Hypersensitivity:
- Hypersensitivity reaction
-
Respiratory:
- Bronchospasm
Contraindications to Folic Acid (Folate):
Allergy reactions to folic acids or any other component of the formulation
Warnings and precautions
-
Monotherapy for Anemia
- Patients with pernicious anemia, aplastic anemia, and normocytic encephalopathy should avoid it as a monotherapy.
-
Pernicious anemia:
- While irreversible nerve damage is possible, doses exceeding 0.1 mg/day can obscure the symptoms of pernicious Anemia.
Folic acid: Drug Interaction
Risk Factor C (Monitor therapy) |
|
Capecitabine |
Folic Acid may enhance the adverse/toxic effect of Capecitabine. |
Floxuridine |
Folic Acid may enhance the adverse/toxic effect of Floxuridine. |
Fluorouracil (Systemic) |
Folic Acid may enhance the adverse/toxic effect of Fluorouracil (Systemic). |
Fosphenytoin |
Folic Acid may decrease the serum concentration of Fosphenytoin. |
Green Tea |
May decrease the serum concentration of Folic Acid. |
PHENobarbital |
Folic Acid may decrease the serum concentration of PHENobarbital. |
Phenytoin |
Folic Acid may decrease the serum concentration of Phenytoin. |
Primidone |
Folic Acid may decrease the serum concentration of Primidone. Additionally, folic acid may decrease concentrations of active metabolites of primidone (e.g., phenobarbital). |
SulfaSALAzine |
May decrease the serum concentration of Folic Acid. |
Tegafur |
Folic Acid may enhance the adverse/toxic effect of Tegafur. |
Risk Factor D (Consider therapy modification) |
|
Pyrimethamine |
Folic Acid may diminish the therapeutic effect of Pyrimethamine. Management: Folic acid doses greater than 2.5 mg per day should be avoided due to the potential for sulfadoxine/pyrimethamine treatment failure. Consider limiting folic acid use to no more than 0.4 mg per day for women of child-bearing age. |
Sulfadoxine |
Folic Acid may diminish the therapeutic effect of Sulfadoxine. Management: Folic acid doses greater than 2.5 mg per day should be avoided due to the potential for sulfadoxine/pyrimethamine treatment failure. Consider limiting folic acid use to no more than 0.4 mg per day for women of child-bearing age. |
Risk Factor X (Avoid combination) |
|
Raltitrexed |
Folic Acid may diminish the therapeutic effect of Raltitrexed. |
Monitoring parameters:
- Monitor for rising blood counts in patients with folate deficiency anemias.
- Observe for neurological signs if administered to patients with macrocytic anemia.
- Avoid folate administration in patients with vitamin B12 deficiency as it may worsen the neurological features associated with vitamin B12 deficiency.
How to administer Folic Acid (Folate)?
- It should preferably be administered per oral.
- However, it can also be administered by a deep Intramuscular injection, SubQ, and intravenous injections.
Intravenous administration:
- Doses 5 mg or less may be administered undiluted over greater than one minute
- It may be administered after dilution in 50 ml NS or 5% DW and infused over 30 minutes.
- Dilution is recommended for doses greater than 5 mg.
- It may also be added to intravenous solutions and given as an intravenous infusion.
Mechanism of action of Folic Acid (Folate):
- Folic acid is essential for many co-enzymes involved in metabolic pathways.
- Folic acid is essential for the synthesis and use of pyrimidine and purines, as well as nucleoproteins and erythropoiesis.
- Folate deficiency patients also benefit from the stimulation of platelets, WBCs and other metabolic processes.
- Folic acid is helpful in the conversion of toxic metabolites of methanol (formic acids) to non-toxic substances in methanol poisoning.
The onset of action:
- Peak effect is seen when administered Orally: 0.5 to 1 hour
Absorption:
- It is absorbed in the proximal part of the small intestine
Metabolism:
- Hepatic
Bioavailability of oral folate:
- Folic acid supplement: about 100%
- In the presence of food: 85%
- Dietary folate: 50%
Time to peak serum concentration after oral administration:
- One hour
Excretion:
- Urine
International Brands of Folic Acid (Folate):
- FA-8
- JAMP-Folic Acid
- NOVO-Folacid
- SANDOZ Folic Acid
- F. Valdecasas
- Acfol
- Acide Folique CCD
- Acido Folico
- Acido Folico Fada
- Acifol
- Anemolat
- Apo-Folic
- Bio-Folic
- Clonfolic
- Conacid
- Elvefocal
- Endofolin
- Enhansid
- Feri
- Filicine
- Fionat
- Folac
- Folacid
- Folacin
- Folart
- Folate
- Folavit
- Folbiol
- Folcid
- Folee-1
- Foli 5
- Foliage
- Foliamin
- Folic Acid DHA
- Folic Acid Pharm Ecologist
- Folicap
- Folicid
- Folicil
- Folicum
- Folimax
- Folimen
- Folimet
- Folin
- Folina
- Folinsyre ”Dak”
- Foliphar
- Folitab
- Folivit
- Folivita
- Folivital
- Foloicare
- Folsan
- Folsyre
- Folverlan
- Folvit
- Folvite
- Gravi-Fol
- Gravida
- Huma-Folacid
- Ingafol
- Lexpec
- Megafol
- Mithra Folic
- Nufolic
- Obstetra
- Prinac AC
- Quatro
- RubieFol
- Tecnovorin
- Tesha-1
- Tifol
- Tonixan
- Travital Folic Acid
- Vifolin
Folic acid (Folate) Brand Names in Pakistan:
Folic Acid Syrup 0.35 mg |
|
G-Tose | Glitz Pharma |
Hiron | Goodman Laboratories |
Folic Acid Tablets 5 mg |
|
Deefol | Delux Chemical Industries |
Delfol | Delta Pharma (Pvt) Ltd. |
Folacin | Pharmedic (Pvt) Ltd. |
Folic | Eros Pharmaceuticals |
Folic Acid | Geofman Pharmaceuticals |
Folic Acid | Karachi Pharmaceutical Laboratory |
Folic Acid | Geofman Pharmaceuticals |
Folic Acid | Zafa Pharmaceutical Laboratories (Pvt) Ltd. |
Folic Acid | Chas. A. Mendoza |
Folic Acid | Albro Pharma |
Folic Acid | Zephyr Pharmatec (Pvt) Ltd. |
Folic Acid | Shaheen Agencies |
Folic Acid | Karachi Pharmaceutical Laboratory |
Folic Acid | Chas. A. Mendoza |
Folic Acid | Irza Pharma (Pvt) Ltd. |
Folic Acid | Zephyr Pharmatec (Pvt) Ltd. |
Folic Acid | Semos Pharmaceuticals (Pvt) Ltd. |
Folic Acid | Albro Pharma |
Folimic | Alliance Pharmaceuticals (Pvt) Ltd. |
Folitab | Nabiqasim Industries (Pvt) Ltd. |
Hasfol | Hassan Pharmaceuticals (Pvt) Ltd. |
Staiflic | Standard Drug Co. |
Zal | Alson Pharmaceuticals |
Folic Acid Tablets 0.35 mg |
|
Megatron Plus | Rotex Medica Pakistan (Pvt) Ltd |
Politoose -F | Karachi Pharmaceutical Laboratory |
Polytos-F | Miracle Pharmaceuticals(Pvt) Ltd |
Folic Acid Capsules 5 mg |
|
Afna-Vit | Jafson Pharmaceuticals (Pvt) Ltd. |
Folic Acid Capsule 0.35 mg |
|
Ferovel | Well & Well Pharma (Pvt) Ltd |